OrbiMed’s Neurogene NGNE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-46,090	Closed	-$10.5M	–	143
2020 Q1	$10.5M	Buy	46,090 +1,090	+2%	+$248K	0.18%	83
2019 Q4	$11.1M	Buy	+45,000	New	+$11.1M	0.16%	81